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The incidence of cancer of the female genital organs is extremely
high. Conservative estimates place the total at more than 20 per
cent of all cancer. The uterus and mammary glands seem espe-
cially vulnerable. Normally these organs are subject to (1) spurts
of growth which (2) prepare them for funtion after which they
(3) undergo retrogression. This generalization appliestoboth non-
pregnant animals during estrous or menstrual cydes and to pregnant
and lactating animals, the times of specific phases varying greatly in
different conditions and species. These phases of growth, function,
and retrogression are regulated by flood and ebb tides of ovarian and
associated hormones.
Without this hormonal stimulation, as after ovariectomy or
hypophysectomy, the vagina, uterus, and mammary glands atrophy.
Replacement therapy with hormones restores normal conditions in
nearly all phases of reproductive functions in experimental animals4
and in women.25 Growth of female genital tissues is -one of the
most fundamental reactions to the ovarian follicular (estrogenic)
hormone.' For instance, when pieces of the uterus are observed in
ocular transplants in the living animal, (1) the vessels dilate within
30 minutes after an injection of estrogenic substance.22 Then (2) a
marked increase in tissue fluids follows.5 Then (3) a wave of
mitotic division, especially noticeable in epithelial genital tissues,
extends throughout the uterus, indicating extremely rapid growth,
so that in 48 or 54 hours the quiescent uterus of the castrate rat or
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mouse is transformed into (4) the actively contracting, estrous uterus
(5) filled with secretion and similar to that of the normal animal
at times of mating.
During this time the wall of the vagina grows so rapidly that a
2 or 3 layered epithelium is replaced by one 12 to 15 cell layers in
thickness. The mammary glands grow also, but more slowly than
the uterus and vagina, a longer period of estrogenic stimulation being
required for full growth.1' Among the varied reactions to estro-
genic hormones, the most significant one is stimulation of growth
of the female genital organs.
After normal reactions had been produced by injecting moderate
amounts of ovarian hormones, quantitative aspects of hormone stimu-
lation were studied extensively. The least amount of estrogen to
produce complete vaginal growth in the rat in 2 days was used as a
standard unit for measurement.3 Then menstrual cydes were pro-
duced experimentally in ovariectomized adult monkeys by injection
of a total of 100 rat units of estrogenic hormone in ten days.1 The
mammary rudiments of the immature male monkey were grown to
the equivalent of the adult non-pregnant female, but it required six
months of estrogenic treatment and thousands of units of hormone.'6
Then the effects on the uterus of estrogens combined Qr in succession
with the second ovarian hormone, progesterone, were worked
out.6 18,26 Synergism between these two hormones (and in some
respects, antagonism) was described. Recently the quantitative
aspects of hormone balance have been extensively studied.4
With these endocrine reactions as a background, our group has
turned to the study ofthe possibilities of inducing abnormal or atypi-
cal growths in female genital organs by long-continued stimulation
with massive doses of estrogenic hormones. The first stimulus in
this direction came from attendance at a lecture on the early diag-
nosis of cervical cancer where slides of epithelium were shown from
a case in which leucoplakia had been observed. It was pointed out
that this might be an early precancerous change. Similar conditions
had been obtained in our experiments with ovariectomized monkeys
injected with follicular hormone.1 So more extensive experiments
were planned to subject monkeys to extreme estrogenic stimulation
continuously,-with no respite for retrogression, as occurs normally,
-and conditions were induced experimentally which closely simu-
lated early cervical carcinoma.24 There was marked epithelial over-
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growth, metaplasia of the mucous glands of the cervix and, when the
cervix was traumatized, penetrating epithelial infiltrations into the
underlying connective tissue. But these growths retrogressed when
hormonal stimulation was stopped. They did not have the ability
to grow independently. This work was considered suggestive but
not decisive. We now know that the estrogenic hormonethen avail-
able was not sufficiently concentrated for production of excessive
atypical growths.
As more potent estrogenic preparations wereproduced, mammary
cancer was reported in male mice feminized by estrogens.20 It had
been known that removal of ovaries from young mice prevented
the development of mammary cancer2' by depriving them of the
ovarian hormones necessary for growth of the mammary glands.
As concentrated estrogenic hormones became available for experi-
mental use, this problem was studied intensively.'4' ' Mice are
ideal experimental animals for such a study.27 They have five pairs
of mammary glands, the anterior ones extending up around the neck
like a lady's fur and the caudal ones extending down to the base of
the tail,-an extreme amount of mammary tissue.
The method of preparing these glands for study" is to slit the
skin in the mid-dorsal line, remove it completely, pin it fur down
to sheet cork, fix in Bouin's solution, dissect off all the glands in their
enveloping fascia, stain in dilute hemalum, clear, dissect off excess
connective tissue under binocular magnification, and mount all ten
glands from each animal. If desired, small pieces may be excised
for microscopic section, but it is remarkable how much detail can be
observed in the whole mounts with low and medium powers of the
compound microscope.
Using this technic, study of ten inbred strains of mice with vary-
ing susceptibilities to mammary cancer at representative ages
throughout life was completed. This study established the back-
ground of control observations.
At the same time injections of estrogens were begun in male mice
of several strains at minimal doses for normal growth of the mam-
mary duct system. Although a few atypical nodular mammary
growths were observed following this "feminization" of the males,
no cancers appeared,1' as previouslydescribed by Lacassagne.20 The
treatment was apparently at a level subthreshold for cancer. With
increased doses the mammary cancers began to appear, until now a
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total of approximately 75 cases of cancer in "feminized" male mice
have been observed. These occurred with treatment starting at
birth or up to 120 days thereafter, and with doses ranging from 100
to 1000 i.u. per week.7 8 The time of appearance of the cancers
ranged from 136 to more than 500 days of age. These mammary
cancers in males on estrogenic treatment are transplantable and con-
tinue to grow in both female and male hosts without continuing
estrogenic treatment of the hosts. Mammary cancers have been
obtained in low as well as in high cancer strains of mice, but not yet
in the very low cancer strain. Another point of interest is that there
is apparently an optimum dose for mammary cancer; -everal times
that which will induce normal growth is still below the cancer
threshold, the optimum dose for mammary cancer in the mice in
these experiments was 300 to 500 i.u. weekly, and greater doses
(1,000 i.u. weekly) have not been followed by cancer.4 This work
confirmed and extended Lacassagne's report and left no doubt of the
importance of estrogenic hormone as one necessary factor in mam-
mary carcinogenesis.
Attention was then turned to the guinea-pig, for frequently a
change of experimental animal will bring to light some new view-
point. Guinea-pigs were injected with 50 rat units of estrogen
daily for periods up to 8 months.23 The first symptom of abnormal
reaction toward the end of treatment was bleeding from the vagina.
In some cases this was severe enough to lead to anemia and death.
The uterus on section showed a condition of extreme cystic hyper-
plasia and endometrial hemorrhage. Button-like fibromyomas,
usually multiple, were present on the peritoneal surface of the
uterus. These represent the first experimentally produced fibromy-
omas ofthe uterus. They have not appeared as yet in other animals
(mice, rats, dogs, and monkeys) on similar treatment. This may
be explainable on the basis of differential species susceptibility,-
similar, for instance, to the incidence of fibromas of the uterus in
negroes which is extremely high while in whites it is relatively low.
Turning again to the mouse as experimental animal,-it has
recentlybeen possible experimentally to meet the usual requisites for
cervical carcinoma. Eighteen tumors which are histologically cer-
vical carcinomas have been obtained in mice on long-continued estro-
genic treatment. They grow rapidly, may infiltrate the musde of
the rectum and neck of the bladder, and metastasize to adjacent
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lymph nodes. The final test of malignancy has been a demonstra-
tion of their transplantability to both male and female hosts, which
survive from 6 to 8 weeks. These transplants have now been passed
through four generations of hosts without continuing estrogenic
treatment of the host. They are therefore truly carcinomas.10
It is of interest to note that cervical carcinoma No. 18 appeared
prolapsing from the vagina only after mammary cancers had twice
been removed from this animal,--in other words, the mammary
cancer appears before the cervical cancer, and must be removed to
allow time for development of the latter.
There are several other effects of long-continued estrogenic
treatment which are now being studied intensively and which may
be classed as atypical growths, although not classifiable as cancer.
The first of these is an extensive metaplasia of the epithelium of
the uterine cornua in mice. It is possible by injecting estrogens in
high doses, starting at very early ages when the uterus is infantile,
to induce proliferation of a several layered stratified epithelium
which completely replaces the single layered columnar epithelium
of the endometrium of the normal animal. If injections are begun
in older animals, cystic hyperplasia of the endometrium develops,
and then pyometra, sometimes severe enough to be fatal. At first
it was thought that this pyometra was an accentuation of the leuko-
cytic infiltration which occurs during the retrogressive phase of the
normal estrous cycle, but later it was shown to be due to invasion of
the uterus by bacteria.28 When one horn of the uterus of a mouse
is transplanted subcutaneously at an early age, and then the animal
is given intensive estrogenic treatment, pyometra develops in the
normally placed horn but not in the transplanted one which is not
open to infection from the outside. It has since been found that
chronic pyometra in old dogs quickly subsides after ovariectomy.
The interpretation of these experiments at present is that continued
intensive estrogenic stimulation may render the uterus susceptible
to infection.
The estrogenic hormone's domination over growth of genital
tissues, especially the epithelium, has been emphasized. It also
produces marked changes in bone. As the female pocket-gopher
approaches puberty the symphysis pubis is resorbed, leaving only a
ligamentous connection and enlarging the pelvic outlet.'7 A similar
enlargement of the birth canal occurs in mice,-not at puberty, but
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toward the end of the first pregnancy, and becomes more prominent
with successive pregnancies. This effect can be produced experi-
mentally in male mice by injecting estrogenic hormone.9 While
pelvic bone is being resorbed, new osseous tissue is being laid down
in the marrow cavities of the long bones, until in extreme cases some
of them may become solidly filled with new bone."2 With percep-
tion sharpened by these experimental results, search of marrow
cavities in normal pregnant mice revealed new spicules of bone
forming late in gestation,-a new observation. Addition of andro-
gen to the effective dose of estrogen prevents the reaction."3
As though obliteration of the marrow cavities had driven out
blood-forming tissue, leukemia appeared in these mice under estro-
genic treatment.7 (Whether the two conditions are related is un-
known.) Lymphatic leukemia, malignant and transplantable, first
as local tumor, then becoming systemic, is now being studied
intensively."9
It must be made clear that ovarian hormones are obviously x'tot
the only cause of female genital cancer,-that estrogens normally
are very important growth stimulators of female genital tissues and,
acting in high concentration, continuously, may produce decidedly
atypical growths and are a determining factor in mammary and
uterine cancer.
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